RY 175.21 -0.3356% SHOP 156.95 -1.084% TD 79.38 0.5192% ENB 61.46 0.8368% BN 85.95 -0.5554% TRI 231.55 0.1384% CNQ 48.135 1.9162% CP 106.345 -0.8161% CNR 153.84 -1.4604% BMO 133.61 0.0449% BNS 77.01 -3.4841% CSU 4681.4302 -2.2727% CM 89.21 -0.9328% MFC 45.15 -0.4849% ATD 82.82 -0.2529% NGT 58.47 1.8464% TRP 68.71 0.6887% SU 54.865 -0.4626% WCN 268.72 0.2238% L 187.14 1.6016%
Company Overview: Graphite One Inc. (TSXV: GPH) is a U.S.-based company focused on the development of its graphite one project, which aims to establish a fully integrated supply chain for high-quality graphite. BriaCell Therapeutics Corp. (NASDAQ: BCTX) is a clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology therapies to treat various forms of cancer. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
On November 27, 2024, the S&P 500 index settled at 5998.74 with a week till date gain of 0.19%; moreover, the tech-heavy NASDAQ composite advanced by ~0.30% on a WTD basis and settled at 19060.48. While, the Russell 2000 settled at 2426.19, reflecting a gain of ~0.81% on a WTD basis.
Considering the Canadian market, the benchmark S&P/TSX Venture Composite Index (TSX: ^JX) started the week on a positive note and continued the momentum. On November 28, 2024, the index closed at 607.69 with an overall week-to-date (WTD) gain of 0.25%. Industrials and technology were the leading sectors, while financials Healthcare, basic materials, consumer cyclicals, energy, and real estate were the laggards on Thursday.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA 
AU
UK
US
NZ
Please wait processing your request...